These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25577957)

  • 61. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oculocutaneous albinism and analysis of tyrosinase gene in Japanese patients.
    Tomita Y; Miyamura Y
    Nagoya J Med Sci; 1998 Oct; 61(3-4):97-102. PubMed ID: 9879192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
    Mondal M; Sengupta M; Ray K
    Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prenatal molecular diagnosis of oculocutaneous albinism (OCA) in a large cohort of Israeli families.
    Rosenmann A; Bejarano-Achache I; Eli D; Maftsir G; Mizrahi-Meissonnier L; Blumenfeld A
    Prenat Diagn; 2009 Oct; 29(10):939-46. PubMed ID: 19626598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
    Onojafe IF; Adams DR; Simeonov DR; Zhang J; Chan CC; Bernardini IM; Sergeev YV; Dolinska MB; Alur RP; Brilliant MH; Gahl WA; Brooks BP
    J Clin Invest; 2011 Oct; 121(10):3914-23. PubMed ID: 21968110
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals].
    Sanabria D; Groot H; Guzmán J; Lattig MC
    Biomedica; 2012 Jun; 32(2):269-76. PubMed ID: 23242301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Study of tyrosinase gene mutation in oculocutaneous albinism type 1 patients].
    Zheng H; Huang ZG; Wen RQ; Li HY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):329-32. PubMed ID: 22097729
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA-based carrier detection and prenatal diagnosis of tyrosinase-negative oculocutaneous albinism (OCA1A).
    Falik-Borenstein TC; Holmes SA; Borochowitz Z; Levin A; Rosenmann A; Spritz RA
    Prenat Diagn; 1995 Apr; 15(4):345-9. PubMed ID: 7617575
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel deletion of exon 3 in TYR gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations.
    Dhangar S; Panchal P; Ghatanatti J; Suralkar J; Shah A; Vundinti BR
    BMC Med Genomics; 2022 Jan; 15(1):2. PubMed ID: 34980106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tyrosinase (TYR) gene sequencing and literature review reveals recurrent mutations and multiple population founder gene mutations as causative of oculocutaneous albinism (OCA) in Pakistani families.
    Shakil M; Harlalka GV; Ali S; Lin S; D'Atri I; Hussain S; Nasir A; Shahzad MA; Ullah MI; Self JE; Baple EL; Crosby AH; Mahmood S
    Eye (Lond); 2019 Aug; 33(8):1339-1346. PubMed ID: 30996339
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A novel P gene mutation in a Chinese family with oculocutaneous albinism].
    Duan HL; Li HY; Wu WQ; Zheng H; Chen Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):614-7. PubMed ID: 17160937
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Tyrosinase missense mutation causes albinism in the Wistar rat.
    Blaszczyk WM; Arning L; Hoffmann KP; Epplen JT
    Pigment Cell Res; 2005 Apr; 18(2):144-5. PubMed ID: 15760344
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Spectrum of pathological genetic variants among 405 Chinese pedigrees affected with oculocutaneous albinism].
    Wang C; Chen C; Zhao X; Zhao G; Liu L; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jul; 37(7):725-730. PubMed ID: 32619251
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Genetic testing and prenatal diagnosis for thirteen Chinese pedigrees affected with oculocutaneous albinism].
    Yang Y; Mao B; Wang Q; Lie S; Zhang R; Zhao X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Feb; 39(2):143-147. PubMed ID: 35076908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene.
    Morice-Picard F; Lasseaux E; Cailley D; Gros A; Toutain J; Plaisant C; Simon D; François S; Gilbert-Dussardier B; Kaplan J; Rooryck C; Lacombe D; Arveiler B
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):59-71. PubMed ID: 24118800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.
    Ray K; Chaki M; Sengupta M
    Prog Retin Eye Res; 2007 Jul; 26(4):323-58. PubMed ID: 17355913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular basis of oculocutaneous albinism type 1 in Lebanese patients.
    Zahed L; Zahreddine H; Noureddine B; Rebeiz N; Shakar N; Zalloua P; Haddad F
    J Hum Genet; 2005; 50(6):317-319. PubMed ID: 15937636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.